Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Although significant progress has been made in elucidating the molecular and cellular mechanisms underlying drug-induced neurotoxicity, key questions remain
Detox: provides support to the liver in eliminating toxins, heavy metals, and harmful chemicals
At 0.25mg per week, a 10mg vial contains 40 weeks of doses
this off-label use is not backed by the same level of controlled human trial evidence as the lipodystrophy indication Known risks and side effects: Injection site reactions, including erythema, pruritus, pain, and bruising at the injection site Arthralgia (joint pain) and peripheral edema (fluid retention), recognized class effects of GH-axis stimulation Increases in blood glucose and reduced insulin sensitivity, with clinical trials showing a higher rate of elevated HbA1c and new-onset hyperglycemia versus placebo Formation of anti-tesamorelin antibodies, reported in a substantial proportion of treated patients, with unclear long-term clinical significance Contraindicated in people with active malignancy, pituitary or hypothalamic disruption, or pregnancy, per FDA labeling Evidence snapshot: The strongest evidence is a set of Phase 3 human randomized controlled trials that supported FDA approval of tesamorelin for reducing visceral abdominal fat in HIV-associated lipodystrophy (approved 2010), plus a separate placebo-controlled human RCT (Baker et al., 2012, Archives of Neurology) showing improved executive function in older adults
Para la atrofia ptica de Leber o la ceguera del fumador, la dosis habitual comienza en 1000mcg, administrada diariamente durante 2 semanas, seguida de dos veces por semana
Once peptides have been received, it is important that they are kept cold and away from light
